Empirical Ventures investment portfolio

Argonaute RNA Limited is a biotechnology company that develops gene-silencing therapeutics using a proprietary platform to stabilize small interfering RNA (siRNA) for the treatment of life-threatening diseases. Their lead programs target cardiovascular conditions, specifically severe familial hypercholesterolaemia, and they collaborate with strategic pharmaceutical partners to address previously "undruggable" medical needs.

Barton Blakeley Technologies Limited develops and operates carbon conversion technology that transforms waste carbon dioxide emissions into industrial materials, such as silica nano powders and lead-free glass. The company targets industrial manufacturers in the automotive, aerospace, and chemical sectors seeking sustainable, low-carbon alternatives for products like tires, coatings, and electronics.